wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26774521-2C6E81DC-A742-4F4A-96F9-B735C6597051
Q26774521-2C6E81DC-A742-4F4A-96F9-B735C6597051
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26774521-2C6E81DC-A742-4F4A-96F9-B735C6597051
Personalized medicine in gastric cancer: Where are we and where are we going?
P2860
Q26774521-2C6E81DC-A742-4F4A-96F9-B735C6597051
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26774521-2C6E81DC-A742-4F4A-96F9-B735C6597051
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a6fd8f3484b49f92d392dc4ea582000aa5ba0fc9
P2860
A phase IIa dose-finding and safety study of first-line pertuzumab in combination with trastuzumab, capecitabine and cisplatin in patients with HER2-positive advanced gastric cancer